SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-19-002423
Filing Date
2019-08-05
Accepted
2019-08-05 17:09:30
Documents
1
Period of Report
2019-07-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2755
  Complete submission text file 0001683168-19-002423.txt   4307
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENETIC BIOSCIENCES, INC. 40 SPEEN STREET FRAMINGHAM MA 01701
Business Address
VINOGRADOV ALEXEY ANDREEVICH (Reporting) CIK: 0001784315 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37937 | Film No.: 19999499